A research to study the benefits and drawbacks of pharmacist provided care comparing to usual medical care in patients taking oral anticoagulant medicines
Not Applicable
- Conditions
- Health Condition 1: null- Atrial fibrillation, DVT (Deep Vein Thrombosis) and Heart Valve Replaced Patients who are on treatment with oral anticoagulants
- Registration Number
- CTRI/2018/01/011059
- Lead Sponsor
- Kiran Majjigeri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients age from 18 years to 80 years of either sex diagnosed with atrial fibrillation, patients undergone valve replacement therapy, patients with DVT or having risk of DVT and should be newly started with Vit-K oral anticoagulants for minimum of three months treatment plan. Patients should know to read English or any of the local languages Kannada, Marathi and Hindi.
Exclusion Criteria
Patients with severe renal insufficiency, who are on dialysis, patients with active liver disease, pregnant patients, bleeding disorders, patients having visual and hearing impairment, Patients suffering from lupus anticoagulant or antiphospholipid syndrome.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method